CNE1000034X1
CNE1000034X1
TIANYU PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 7.72B EUR | 7.02B EUR | 8.14B EUR |
Enterprise Value | 8.97B EUR | 8.29B EUR | 9.34B EUR |
Valuation Multiples | |||
Trailing P/E | 79.21x | 81.56x | 73.64x |
Forward P/E | 35.21x | -- | -- |
Price to Sales | 2.34x | 1.95x | 2.58x |
Price to Book | 2.15x | 1.97x | 2.21x |
EV/Revenue | 2.72x | 2.31x | 2.96x |
EV/EBITDA | 16.52x | 34.56x | 34.43x |
Price to FCF (P/FCF) | 11.95x | 23.53x | 269.03x |
EV/FCF | 13.88x | 27.8x | 308.94x |
FCF Yield | 8.37% | 4.25% | 0.37% |